Abstract:Over the past two decades medical researchers and modernist feminist researchers have contested the meaning of menopause. In this article we examine various meanings of menopause in major medical and feminist literature and the construction of menopause in a semi-structured interview study of general practitioners in rural South Australia. Three discursive themes are identified in these interviews; (i) .the hormonal menopause - symptoms, risk, prevention; (ii). the informed menopausal woman; and (iii). decision-making and hormone replacement therapy. By using the discourse of prevention, general practitioners construct menopause in relation to women's health care choices, empowerment and autonomy. We argue that the ways in which these concepts are deployed by general practitioners in this study produces and constrains the options available to women. The implications of these general practitioner accounts are discussed in relation to the proposition that medical and feminist descriptions of menopause posit alternative but equally-fixed truths about menopause and their relationship with the range of responses available to women at menopause. Social and cultural explanations of disease causality (c.f. Germov 1998, Hardey 1998) are absent from the new menopause despite their being an integral part of the framework of the women's health movement and health promotion drawn on by these general practitioners. Further, the shift of responsibility for health to the individual woman reinforces practice claims to empower women, but oversimplifies power relations and constructs menopause as a site of self-surveillance. The use of concepts from the women's health movement and health promotion have nevertheless created change in both the positioning of women as having 'choices' and the positioning of some general practitioners in terms of greater information provision to women and an attention to the woman's autonomy. In conclusion, we propose that a new menopause has evolved from a discursive shift in medicine and that there exists within this new configuration, claiming the empowerment of women as an integral part of health care for menopause, the possibility for change in medical practice which will broaden, strengthen, and maintain this position.

Untangling the web between menopause and respiratory disease

Effects of Hormone Replacement Therapy on Women's Lung Health and Disease

Promoting good mental health over the menopause transition

Menopause as a window of opportunity: the benefits of designing more effective theory-driven behaviour change interventions to promote healthier lifestyle choices at midlife

The role of menopausal symptoms on future health and longevity: A systematic scoping review of longitudinal evidence

Female reproductive histories and the risk of chronic obstructive pulmonary disease

A systematic review and meta-analysis investigating differences in chronic inflammation and adiposity before and after menopause

From cardiovascular protection to cardiovascular risk: the metamorphosis of menopausal hormone therapy

Intersection of menstrual and menopausal health with mental health: implications for general practice

Menopause in the workplace; what’s everyone getting in a sweat about

Chinese Expert Consensus on the Diagnosis, Treatment, and Management of Asthma in Women Across Life.

Effects of menopause and fat mass in asthmatic inflammation

Abstract P068: The Relationship Of Air Pollution And Menopause On The Progression Of Coronary Artery Calcification In Midlife Women: Study Of Women’s Health Across The Nation

Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need

Obesity and menopause

Menopausal women struggling with symptoms at work – a conundrum unsolved?

Perimenopausal and Postmenopausal Health

Cardiovascular disease in menopause: Does the obstetric history have any bearing?

Menopause as a long-term risk to health: implications of general practitioner accounts of prevention for women's choice and decision-making

Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial

Oxytocin and women's health in midlife